Functional properties of muscarinic receptor subtypes Hm1, Hm3 and Hm5 expressed in Sf9 cells using the baculovirus expression system

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 2, 1996, Pages 593-601

  Kukkonen, Jyrki P ^a   Näsman, Johnny ^a   Ojala, Pekka ^a   Oker Blom, Christian ^a,b   Åkerman, Karl E O ^a  

^a ÅBO AKADEMI UNIVERSITY   (Finland)

^b VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CARBACHOL; DIGITONIN; INOSITOL 1,4,5 TRISPHOSPHATE; METHYLSCOPOLAMINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M5 RECEPTOR; OXOTREMORINE; PILOCARPINE; PIRENZEPINE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BACULOVIRUS; CALCIUM MOBILIZATION; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DRUG POTENCY; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DENSITY; RECEPTOR UPREGULATION; SECOND MESSENGER; VIRUS INFECTION;

ANIMALS; BACULOVIRIDAE; CALCIUM; CARBACHOL; GTP-BINDING PROTEINS; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE; MUSCARINIC AGONISTS; RECEPTORS, MUSCARINIC; RECOMBINANT PROTEINS; SPODOPTERA;

EID: 0030436562     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. 2+ mobilisation in SH-SY5Y neuroblastoma cells through different mechanisms. J. Neurochem. 54: 497-504, 1990.
2. AKIBA, I., KUBO, T., MAEDA, A., BUJO, H., NAKAI, J., MISHINA, M. AND NUMA, S.: Primary structure of porcine mAChR III and antagonist binding studies. FEBS Lett. 235: 257-261, 1988.
3. BIRDSALL, N. J. M., CHAN, S.-C., EVELEIGH, P., HULME, E. C. AND MILLER, K. W.: The modes of binding of ligands to cardiac muscarinic receptors. Trends Pharmacol. Sci. Supplement December 1989: 31-34, 1989.
4. BLUML, K., MUTSCHLER, E. AND WESS, J.: Functional role of a cytoplasmic aromatic amino acid in muscarinic receptor-mediated activation of phospholipase C. J. Biol. Chem. 269: 11537-11541, 1994.
5. BONNER, T. I., BUCKLEY, N. J., YOUNG, A. C. AND BRANN, M. R.: Identification of a family of muscarinic acetylcholine receptors. Science (Wash. DC) 237: 527-532, 1987.
6. BONNER, T. I., YOUNG, A. C., BRANN, M. R. AND BUCKLEY, N. J.: Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes. Neuron 1: 403-410, 1988.
7. BONNER, T. I.: The molecular basis for muscarinic receptor diversity. Trends Neurosci. 12: 148-15, 1989.
8. BRADFORD, M. M.: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Chem. 72: 248-254, 1976.
9. BROWN, E., KENDALL, D. A. AND NAHORSKI, S. R.: Inositol phospholipid hydrolysis in rat cerebral cortical slices: I. Receptor characterisation. J. Neurochem. 42: 1379-1387, 1984.
10. BROWN, J. H. AND MCDONOUGH, P.: Muscarinic cholinergic receptor regulation of inositol phospholipid metabolism and calcium mobilization. In The Muscarinic Receptors, ed. by J. H. Brown, pp. 259-307, Humana Press, Clifton, NJ, 1989.
11. BUJO, H., NAKAI, J., KUBO, T., FUKUDA, K., AKIBA, I., MAEDA, A., MISHINA, M. AND NUMA, S.: Different sensitivity to agonists of muscarinic acetylcholine receptor subtypes. FEBS Lett. 240: 95-100, 1988.
12. 1A receptors in Sf9 cells. Reconstitution of a coupled phenotype by co-expression of mammalian G protein subunits. J. Biol. Chem. 270: 18691-18699, 1995.
13. CAUFIELD, M. P.: Muscarinic receptors-characterization, coupling and function. Pharmac. Ther. 58: 319-379, 1993.
14. COUPRY, L., DUZIC, E. AND LANIER, S. M.: Factors determining the specificity of signal transduction by guanine nucleotide-binding protein-coupled receptors. J. Biol. Chem. 167: 9852-9860, 1992.
15. 3 muscarinic receptors in rat parotid gland couple to two second messenger systems. Am. J. Physiol. 261(6 Pt. 1): C1063-1073, 1991.
16. 3H]methyl-scopolamine binding. Their relationship with calcium 45 efflux and amylase secretion. J. Biol. Ghem. 259: 294-300, 1984.
17. DÖRJE, F., WESS, J., LAMBRECHT, G., TACKE, R., MUTSCHLER, E. AND BRANN, M. R.: Antagonist binding profiles of five cloned human mAChR subtypes. J. Pharmacol. Exp. Ther. 256: 727-733, 1991.
18. ENSINGER, H. A., DOODS, H. N., IMMEL-SEHR, A. R., KUHN, F. J., LAMBRECHT, G., MENDLA, K. D., MULLER, R. E., MUTSCHLER, E., SAGRADA, A., WALTHER, G. AND HAMMER, R.: WAL-2014 - A muscarinic agonist with preferential neuronstimulating properties. Life Sci. 52: 473-480, 1993.
19. FELDER, C. C., DIETER, P., KINSELLA, J., TAMURA, K., KANTERMAN, R. Y. AND AXELROD, J.: A transfected m5 muscarinic acetylcholine receptor stimulates phospholipase A2 by inducing both calcium influx and activation of protein kinase C. J. Pharmacol. Exp. Ther. 255: 1140-1147, 1990.
20. FELDER, C. C., KANTERMAN, R. Y., MA, A. L. AND AXELROD, J.: A transfected muscarinic acetylcholine receptor stimulates adenylate cyclase via phosphatidylinositol hydrolysis. J. Biol. Chem. 264: 20356-20362, 1989.
21. FISHER, S. K., KLINGER, P. D. AND AGRANOFF, B. W.: Muscarinic agonist binding and phospholipid turnover in brain. J. Biol. Chem. 258: 7358-7363, 1983.
22. FISHER, S. K. AND SNIDER, R. M.: Differential receptor occupancy requirements for muscarinic cholinergic stimulation of inositol hydrolysis in brain and in neuroblastomas. Mol. Pharmacol. 32: 81-90, 1987.
23. FRASER, C. M., WANG, C.-D., ROBINSON, D. A., COCAYNE, J. D. AND VENTER, J. C.: Site-directed mutagenesis of m1 muscarinic acetylcholine receptors: Conserved aspartic acid residues play important roles in receptor function. Mol. Pharmacol. 36: 840-847, 1989.
24. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 3440-3450, 1985.
25. GUAN, X.-M., KOBILKA, T. S. AND KOBILKA, B. K: Enhancement of membrane insertion and function in a type IIIb membrane protein following introduction of a cleavable signal peptide. J. Biol. Chem. 267: 21995-21998, 1992.
26. GURWITZ, D., HARING, R., HELDMAN, E., FRASER, C., MANOR, D. AND FISHER, A.: Discrete activation of transduction pathways associated with acetylcholine m1 receptor by several muscarinic ligands. Eur. J. Pharmacol. 267: 21-31, 1994.
27. HEIKKILÄ, J. E., SCOTT, I. G., SUOMINEN, L. A. AND ÅKERMAN, K. E. O.: Differentiation associated decrease in mAChR sensitivity in human neuroblastoma cells. J. Cell. Physiol. 130: 157-165, 1987.
28. 2+ mobilization and cAMP production in SH-SY5Y and IMR-32 neuroblastoma cells. Eur. J. Pharmacol. 208: 9-15, 1991.
29. HOTH, M. AND PENNER, R.: Calcium release-activated calcium current in rat mast cells. J. Physiol. 465: 359-386, 1993.
30. JACOBSON, M. D., WUSTEMAN, M. AND DOWNES, C. P.: Muscarinic receptors and the hydrolysis of inositol phospholipids in rat cerebral cortex and parotid gland. J. Neurochem. 44: 465-472, 1985.
31. JANSSON, C. C., KARP, M., OKER-BLOM, C., NÄSMAN, J., SAVOLA, J.-M. AND ÅKERMAN, K. E. O.: Two human α2-adrenoceptor subtypes α2A-C10 and α2B-C2 expressed in Sf9 cells couple to transduction pathway resulting in opposite effects on cAMP production. Eur. J. Pharmacol. 290: 75-83, 1995.
32. JONES, S. V. P., HEILMAN, C. J. AND BRANN, M. R.: Functional responses of cloned muscarinic receptors expressed in CHO-K1 cells. Mol. Pharmacol. 40: 242-247, 1991.
33. KASHIHARA, K., VARGA, E. V., WAITE, S. L., ROESKE, W. R. AND YAMAMURA, H. I.: Cloning of the rat m3, m4 and m5 muscarinic acetylcholine receptor genes by the polymerase chain reaction (PCR) and the pharmacological characterisation of the expressed genes. Life Sci. 51(12): 955-971, 1992.
34. KENAKIN, T.: Pharmacologic Analysis of Drug-Receptor Interaction, 2nd edition. Raven Press, New York, NY, 1993.
35. KENAKIN, T. AND BOSELLI, C.: Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: Resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea. J. Pharmacol. Exp. Ther. 250: 944-952, 1989.
36. 2+mobilization and Northern blotting. J. Pharmacol. Exp. Ther. 263: 1487-1493, 1992.
37. 2+ and inositol 1,4,5-triphosphate mass in a human neuroblastoma cell line SH-SY5Y. Biochem. J. 265: 555-562, 1990.
38. LAZARENO, S., FARRIES, T. AND BIRDSALL, N. J. M.: Pharmacological characterization of guanine nucleotide exchange reactions in membranes from CHO cells stably transfected with human muscarinic receptors m1-m4. Life Sci. 52: 449-456, 1993.
39. LECHLEITER, J., PERALTA, E. AND CLAPHAM, D.: Diverse functions of muscarinic acetylcholine receptor subtypes. Trends. Pharmacol. Sci. Suppl., December 1989: 34-38, 1989.
40. 2-adrenergic receptors. J. Biol. Chem. 268: 7949-7957, 1993.
41. LIAO, C.-F., SCHILLING, W. P., BIRNBAUMER, M. AND BIRNBAUMER, L.: Cellular responses to stimulation of the m5 muscarinic acetylcholine receptor as seen in murine L cells. J. Biol. Chem. 265: 11273-11284, 1990.
42. LOUIE, D. S. AND OWYANG, C.: Muscarinic receptor subtypes on rat pancreatic acini: Secretion and binding studies. Am. J. Physiol. 251(2 Pt 1): G275-279. 1986.
43. LUCKOW, V. A. AND SUMMERS, M. D.: Trends in the development of baculovirus vectors. Bio/Technology 6: 47-55, 1988.
44. MAGGIO, R., VOGEL, Z. AND WESS, J.: Reconstitution of functional muscarinic receptors by coexpression of amino- and carboxyl-terminal receptor fragments. FEBS Lett. 319: 195-200, 1993.
45. MCKINNEY, M., STENSTROM, S. AND RICHELSON, E.: Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Mediation of separate responses by high affinity and low affinity agonist-receptor conformations. Mol. Pharmacol. 27: 223-235, 1985.
46. MEI, L., LAI, J., YAMAMURA, H. I. AND ROESKE, W. R.: The relationship between agonist states of the m1 mAChR and the hydrolysis of inositol lipids in transfected fibroblasts (B82) expressing different receptor densities. J. Pharmacol. Exp. Ther. 251: 90-97, 1989.
47. MEI, L., LAI, J., YAMAMURA, I. AND ROESKE, W.: Pharmacologic comparison of selected agonists for the M1 mAChR in transfected murine fibroblast cells (B82). J. Pharmacol. Exp. Ther. 256: 689-694, 1991.
48. MERRITT, J. E. AND RINK, T. J.: Rapid increases in cytosolic free calcium in response to muscarinic stimulation of rat parotid acinar cells. J. Biol. Chem. 262: 4958-4960, 1987.
49. NEHER, E., MARTY, A., FUKUDA, K., KUBO, T. AND NUMA, S.: Intracellular calcium release mediated by two mAChR subtypes. FEBS Lett. 240: 88-94, 1988.
50. NILVEBRANT, L. AND SPARF, B.: Differences between binding affinities of some antimuscarinic drugs in the parotid gland and those in the urinary bladder and ileum. Acta Pharmacol. Toxicol. 53(4): 304-313, 1983.
51. OKER-BLOM, C., JANSSON, C., KARP, M., LINDQVIST, C., SAVOLA, J.-M., VLAK, J. AND ÅKERMAN, K. E. O.: Functional analysis of the human alpha 2C-C4 adrenergic receptor in insect cells expressed by a luciferase-based baculovirus vector. Biochim. Biophys. Acta 1176: 269-75, 1993.
52. i and the accumulation of inositol phosphates in vasopressin-stimulated hepatocytes. Biochem. J. 238: 491-499, 1986.
53. PARKER, E. M., KAMEYAMA, K., HIGASHIJIMA, T. AND ROSS, E. M.: Reconstitutively active G protein-coupled receptors purified from baculovirus-infected insect cells. J. Biol. Chem. 266: 519-27, 1991.
54. PERALTA, E. G., ASHKENAZI, A., WINSLOW, J. W., SMITH, D. H., RAMACHANDRAN, J. AND CAPON, D. J.: Distinct primary structures, ligand binding and tissue specific expression of four human muscarinic acetylcholine receptors. EMBO J. 6: 3923-3929, 1987.
55. PERALTA, E. G., ASHKENAZI, A., WINSLOW, J. W., RAMACHANDRAN, J. AND CAPON, D. J.: Differential regulation of PI hydrolysis and adenylyl cyclase by muscarinic receptor subtypes. Nature (Lond.) 334: 434-437, 1988.
56. REILANDER, H., BOEGE, F., VASUDEVAN, S., MAUL, G., HEKMAN, M., DEES, C., HAMPE, W., HELMREICH, E. J. AND MICHEL, H.: Purification and functional characterization of the human beta 2-adrenergic receptor produced in baculovirus-infected insect cells. FEBS Lett. 282: 441-444, 1991.
57. RINGDAHL, B.: Selectivity of partial agonists related to oxotremorine based on differences in muscarinic receptor reserve between guinea pig ileum and urinary bladder. Mol. Pharmacol. 31: 351-356, 1987.
58. RINKEN, A.: Subtype-specific changes in ligand binding properties after solubilization of muscarinic receptors from baculovirus infected Sf9 insect cell membranes. J. Pharmacol. Exp. Ther. 272: 8-14, 1995.
59. RINKEN, A., KAMEYAMA, K., HAGA, T. AND ENGSTÖM, L.: Solubilization of muscarinic receptor subtypes from baculovirus infected Sf9 insect cells. Biochem. Pharmacol. 48(6): 1245-1251, 1994.
60. SANDMANN, J., PERALTA, E. G. AND WURTMAN, R. J.: Coupling of transfected muscarinic acetylcholine receptor subtypes to phospholipase D. J. Biol. Chem. 266: 6031-6034, 1991.
61. SAVARESE, T. M., WANG, C.-D. AND FRASER, C. M.: Site-directed mutagenesis of the rat m1 muscarinic acetylcholine receptor. J. Biol. Chem. 267: 11439-11448, 1992.
62. SCHWARZ, R. D., DAVIS, R. E., JAEN, J. C., SPENCER, C., TECLE, H. AND THOMAS, A. J.: Characterization of muscarinic agonists in recombinant cell lines. Life Sci. 52: 465-472, 1993.
63. STRANGE, P. G., BIRDSALL, N. J. AND BURGEN, A. S.: Ligand-binding properties of the muscarinic acetylcholine receptor in mouse neuroblastoma cells. Biochem. J. 172: 495-501, 1978.
64. SUMMERS, M. D. AND SMITH, G. E.: A manual of methods for baculovirus vectors and insect cell culture procedures, Texas Agriculture Experiment Station Bulletin No. 1555. Texas Agriculture Experiment Station, College Station, TE, 1987.
65. TAYLOR, C. W.: The role of G proteins in transmembrane signalling. Biochem. J. 272: 1-13, 1990.
66. VASUDEVAN, S., PREMKUMAR, L., STOWE, S., GAGE, P. W., REILANDER, H. AND CHUNG, S. H.: Muscarinic acetylcholine receptor produced in recombinant baculovirus infected Sf9 insect cells couples with endogenous G-proteins to activate ion channels. FEBS Lett. 311: 7-11, 1992.
67. WESS, J., BRANN, M. R. AND BONNER, T. I.: Identification of a small intracellular region of the muscarinic m3 receptor as a determinant of selective coupling to PI turnover. FEBS Lett. 258: 133-136, 1989.
68. WESS, J., BONNER, T. I., DÖRJE, F. AND BRANN, M. R.: Delineation of mAChR domains conferring selectivity of coupling to guanine nucleotide-binding proteins and second messengers. Mol. Pharmacol. 38: 517-523, 1990.
69. WESS, J., GDULA, D. AND BRANN, M. R.: Site-directed mutagenesis of the m3 muscarinic receptor: Identification of a series of threonine and tyrosine residues involved in agonist and antagonist binding. EMBO J. 10: 3729-3734, 1991.
70. WESS, J., MAGGIO, R., PALMER, J. R. AND VOGEL, Z.: Role of conserved threonine and tyrosine residues in acetylcholine binding and muscarinic receptor activation. J. Biol. Chem, 267: 19313-19319, 1992.
71. WESS, J., NANAVATI, S., VOGEL, Z. AND MAGGIO, R.: Functional role of proline and tryptophan residues highly conserved among G protein-coupled receptors studied by mutational analysis of the m3 muscarinic receptor. EMBO J. 12: 331-338, 1993.
72. YANG, J., LOGSDON, C. D., JOHANSEN, T. E. AND WILLIAMS, J. A.: Human m3 muscarinic acetylcholine receptor carboxyl-terminal threonine residues are required for agonist-induced receptor down-regulation. Mol. Pharmacol. 44: 1158-1164, 1993.
73. ZHU, S. Z., WANG, S. Z., HU, J. AND EL-FAKAHANY, E. E.: An arginine residue conserved in most G protein-coupled receptors is essential for the function of the m1 muscarinic receptor. Mol. Pharmacol. 45: 517-523, 1993.